Skip to main content

Table 1 Characteristics of the antibodies used

From: Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules

Antibody

Clone

Dilution

Antigen retrieval

Company

CK19

RCK108

1:100

HIER EDTA Buffer

Dako Corp

HBME

HBME-1

1:50

HIER EDTA Buffer

Dako Corp

Galectin 3

9C4

1:100

HIER Citrate Buffer

Leica Microsystems

Ret Oncoprotein

3F8

1:40

HIER EDTA Buffer

Leica Microsystems

  1. Dako Corporation, Carpentaria, California
  2. Leica Microsystems, Bannockburn, Illinois
  3. CK19: cytokeratin 19